Is KV.A a good stock to own? Find out who bought K-V Pharmaceutical Company, who sold K-V Pharmaceutical Company (KV.A) stock, and who holds a large position in K-V Pharmaceutical Company.

• OrbiMed Advisors owns 6.02M shares worth $7.94M
• Kingdon Capital Management owns 3.64M shares worth $1.97M
• Vanguard owns 1.41M shares worth $1.86M
• D. E. Shaw & Co owns 1.31M shares worth $705159
• Broadfin Capital owns 1.10M shares worth $1.45M
• TSP Capital Management owns 1.07M shares worth $579428
• STATE STREET CORPORATION owns 841295 shares worth $1.11M
• AQR Capital Management owns 640200 shares worth $345708
• Balyasny Asset Management owns 635813 shares worth $839273
• J. Goldman & Co owns 347100 shares worth $485940
• Geode Capital Management owns 304072 shares worth $401375
• Luke P. La Valle, Jr. owns 301625 shares worth $162877
• TIAA-CREF Investment Management owns 247080 shares worth $326145
• Jacobs Levy Equity Management owns 229913 shares worth $303485
• Sabretooth Capital Management owns 220000 shares worth $1.32M
• GLG owns 218977 shares worth $289049
• Partner Fund Management owns 174897 shares worth $230864
• GOLDMAN SACHS owns 142394 shares worth $76892
• CalPERS owns 138225 shares worth $6911
• Oppenheimer & Co owns 128137 shares worth $69193
• Millennium Management owns 125850 shares worth $166122
• Silver Point Capital owns 100000 shares worth $54000
• Barclays owns 100000 shares worth $140000
• FIRST NEW YORK SECURITIES owns 96000 shares worth $134400
• Bank of America Corporation owns 90000 shares worth $126000
• UBS AG owns 78617 shares worth $42453
• Charles Schwab Investment Management owns 69000 shares worth $91080
• CITADEL ADVISORS owns 64440 shares worth $34797
• SSI Investment Management owns 59925 shares worth $80898

• Citi sold on Sept. 30, 2011
• Adage Capital Partners GP sold on June 30, 2011
• Valinor Management sold on June 30, 2011
• Deerfield Management Company sold on June 30, 2011
• Beach Point Capital Management sold on June 30, 2011
• RCM Capital Management sold on June 30, 2011
• Cowen sold on June 30, 2011
• Courage Capital Management sold on June 30, 2011
• Credit Suisse AG sold on June 30, 2011
• Johnson Investment Counsel sold on June 30, 2011
• Perceptive Advisors sold on June 30, 2011
• RHUMBLINE ADVISERS sold on June 30, 2011
• Visium Asset Management sold on March 31, 2011
• Partner Investment Management sold on March 31, 2011
• Bridger Management sold on March 31, 2011
• Hudson Bay Capital Management sold on March 31, 2011
• Mariner Investment sold on March 31, 2011
• Renaissance Technologies sold on March 31, 2011
• GLG Partners sold on March 31, 2011
• Ramius sold on March 31, 2011
• WS Capital Management sold on March 31, 2011
• Sabretooth Capital Management sold on March 31, 2011
• Blue Mountain Capital Management sold on March 31, 2011
• Soros Fund Management sold on March 31, 2011
• --- -------------------- ----- sold on March 31, 2011
• First Heartland Consultants sold on March 31, 2011
• Bascom Hill Partners sold on March 31, 2011
• Knight Capital sold on March 31, 2011
• Prescott Group Capital Management sold on Dec. 31, 2010
• FMR sold on Dec. 31, 2010
• Alyeska Investment sold on Dec. 31, 2010
• Fore Research & Management sold on Dec. 31, 2010
• Inves sold on Dec. 31, 2010
• Technical Financial Services sold on Dec. 31, 2010
• Parametric Portfolio Associates sold on Dec. 31, 2010
• Norges Bank Investment Management sold on March 31, 2009

• Abbott Laboratories (ABT)
• InterMune (ITMN)
• Johnson & Johnson (JNJ)
• Eli Lilly & Co. (LLY)
• Pfizer (PFE)
• Bristol Myers Squibb (BMY)
• Kraft Foods (KFT)
• Medtronic (MDT)
• Merck & Co (MRK)
• Stryker Corporation (SYK)
• UnitedHealth (UNH)
• WellPoint (WLP)
• Biogen Idec (BIIB)
• Gilead Sciences (GILD)
• Shire (SHPGY)
• Watson Pharmaceuticals (WPI)
• K-V Pharmaceutical Company (KV.A)
• Salix Pharmaceuticals (SLXP)
• Celgene Corporation (CELG)
• Medivation (MDVN)
• Amarin Corporation (AMRN)